Johann Trenkwalder

VOLKSWAGEN FINANCIAL SERVICES AG engages in the provision of automotive financial services. It operates through the following segments: Banking, Leasing, Insurance and Service, Mobility, and Payment. The Banking segment comprises retail financing, wholesale financing, as well as factoring and deposits. The Leasing segment offers finance lease and operating lease. The Insurance and Service segment includes motor and telematics, warranty, commercial lines, full and limited maintenance, tires, as well as service and inspection. The Mobility segment focuses on fleet, rental, parking, as well as charge and fuel. The Payment segment specializes in in-car payment, mobile payment, and wallet. The company was founded in 1994 and is headquartered in Braunschweig, Germany.

Volkswagen Group of America, Inc. manufactures and sells motor vehicles and operates a manufacturing plant in Chattanooga, Tennessee. The firm sells different brands of cars including Audi, Bentley, Bugatti, Lamborghini, and Volkswagen, as well as VW Credit. The company was founded in 1955 and is headquartered in Herndon, VA.

SAIC Volkswagen Automotive Co., Ltd. manufactures cars and engines. It is a joint venture of Volkswagen AG and Shanghai Automotive Industry Corporation. The company was founded in March, 1985 and is headquartered in Shanghai, China.

Volkswagen (China) Investment Co., Ltd. engages in the provision of investment services. The company was founded on February 4, 1999 and is headquartered in Beijing, China.

GenoEnergie Karlstadt eG sells energy equipment. The private company is based in Karlstadt, Germany. The German company was founded in 2010. The CEO is Andreas Fella.

Lexogen GmbH is a next generation sequencing (NGS) and transcriptomics company based in Vienna, Austria. Lexogen is the inventor of 3 RNA sequencing, a unique technology that is proven for its efficiency, robustness, and sensitivity, especially unmatched for differential gene expression analysis. The Austrian company's proprietary portfolio includes innovative kits for true single-cell as well as bulk RNA sequencing, RNA extraction, ribosomal RNA depletion, spike-in RNA variant controls, and kinetic RNA labeling. Lexogen also provides first-class, fully integrated NGS services from experimental design to analytical reporting. The mission of the Lexogen team is to empower their customers with innovative top quality RNA analysis solutions and support, in order to improve health and well-being for everyone and our planet. Thousands of scientists all over the world are using their technologies and products. The private company was founded in 2007 by Alexander Seitz, and the CEO is Stéphane Barges.